Document is current
Any future updates will be listed below
-
Authors
Thomas, Kerri R.
Allenspach, Eric J. http://orcid.org/0000-0001-7346-5835
Camp, Nathan D.
Wray-Dutra, Michelle N.
Khim, Socheath
Zielinska-Kwiatkowska, Anna
Timms, Andrew E.
Loftus, Joseph P.
Liggitt, H. Denny
Georgopoulos, Katia http://orcid.org/0000-0002-8963-4258
Tasian, Sarah K. http://orcid.org/0000-0003-1327-1662
James, Richard G. http://orcid.org/0000-0002-2302-7367
Rawlings, David J. http://orcid.org/0000-0002-0810-1776
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1K08CA184418, 1U01CA232486, 1U01CA243072)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Defense (CA180683P1)
V Foundation for Cancer Research
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI-R01CA201135-A1)
- License Information
-
More Information
Article History
Received: 21 January 2021
Revised: 9 June 2021
Accepted: 11 June 2021
First Online: 30 June 2021
Competing interests
: SKT receives research funding from Incyte Corporation, Gilead Sciences, and MacroGenics, Inc. for unrelated studies and is a member of the scientific advisory board of Aleta Biotherapeutics for unrelated studies.
